BARD ABG 100 INTRAVASCULAR OXYGEN MONITOR SYSTEM— 510(k) K884063

Substantially Equivalent

C.R. Bard, Inc.

FDA 510(k) clearance K884063 for BARD ABG 100 INTRAVASCULAR OXYGEN MONITOR SYSTEM, Substantially Equivalent on 1988-12-16. Applicant: C.R. Bard, Inc..

Clearance details

Applicant: C.R. Bard, Inc.
Product code: Code CCE
Advisory panel: Anesthesiology
Date received: 1988-09-26
Decision date: 1988-12-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tewksbury, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.